- Filed
- Oct 29, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Oct 11, 2024 | 136.46M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 109.54M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 28.16B sh |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$84.3K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$79.49K |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $2.01K |
| Cash And Equivalents | Q1 2024 · Mar 31, 2023 | $87.62K |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | −$4.9M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | −$4.64M |
| Stockholders Equity restated | Q1 2024 · Mar 31, 2023 | −$5.28M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | −$5.9M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $4.78M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $4.47M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $4.97M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $4.66M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $65.57K |
| Current Assets | Q1 2024 · Dec 31, 2023 | $26.32K |
| Total Assets | Q1 2024 · Mar 31, 2024 | $65.57K |
| Total Assets | Q1 2024 · Dec 31, 2023 | $26.32K |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | −$0.01 |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | $0.00 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | −$0.01 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | $0.00 |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $31.25K |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $76.58K |
| Net Income | Q1 2024 · Mar 31, 2024 | −$551.88K |
| Net Income | Q1 2024 · Mar 31, 2023 | $617.64K |
| Operating Income | Q1 2024 · Mar 31, 2024 | −$195.75K |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$383.47K |
| Gross Profit | Q1 2024 · Mar 31, 2023 | $4.48K |